Medical News

RSS

22nd Century initiates enrollment in Phase II-B clinical trial of X-22 for smoking cessation

22nd Century Group, Inc., a company focused on smoking cessation and tobacco harm reduction products, today announced that its wholly-owned subsidiary, 22nd Century Limited, LLC, enrolled the first patients in its Phase II-B clinical trial for X-22, a prescription smoking cessation aid in development.

8 Aug 2011

American Shared Hospital Services first half 2011 revenues increase 4.0% to $8,573,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the second quarter and first half of 2011.

8 Aug 2011

AMRI second quarter total revenue increases 9% to $53.9 million

AMRI today reported financial and operating results for the second quarter ended June 30, 2011.

8 Aug 2011

Aultman Hospital selects ProVation Order Sets

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Aultman Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the hospital's electronic order set solution.

8 Aug 2011

Group Health study finds higher dementia risk with atrial fibrillation

The most common kind of chronically irregular heartbeat, known as atrial fibrillation, is associated with a greater risk of dementia, including Alzheimer's disease. This discovery by scientists at Group Health Research Institute and their collaborators was published online in advance of print on August 1 in the Journal of the American Geriatrics Society.

8 Aug 2011

Cook Medical launches Doppler DP-M350 Blood Flow Monitor

In an effort to provide surgeons and nurses with an advanced tool to better monitor blood flow during free flap procedures, Cook Medical has launched the Doppler DP-M350 Blood Flow Monitor, a medical device at the forefront of transplant and reconstructive surgery.

8 Aug 2011

Former OMB health policy adviser tapped to lead Penn medical ethics department

Ezekiel J. Emanuel, a well-known bioethicist who has worked at the National Institutes of Health and until recently was special health-policy adviser to the White House Office of Management and Budget's director, will join the University of Pennsylvania faculty on Sept. 1.

8 Aug 2011

Masimo lifts voluntary product recall of Pronto-7 noninvasive finger sensor

Masimo announced today that it has lifted the voluntary product recall the company imposed on the noninvasive finger sensor of its Pronto-7 handheld device to improve the product's performance in low ambient temperatures. The Pronto-7 and new finger sensors are pending FDA 510(k) clearance in the U.S.

8 Aug 2011

Inhibitex second quarter net loss decreases to $5.3 million

Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2011 and provided an update on several recent clinical and corporate developments.

8 Aug 2011

Health care sector shows muscle in job report

The health care industry added 31,300 jobs last month, higher than its average monthly increase since 2007.

8 Aug 2011

HPV-related throat cancer cases increase sharply over the past 10 years

Forty-two-year-old Manahawkin, New Jersey resident David Caldarella can recite a long list of dates off the top of his head. The first one starts with the day he found a lump on the right side of his neck while shaving. It was March 23, 2010. Caldarella immediately called his physician.

8 Aug 2011

Number of cancer survivors to increase exponentially

The field of survivorship is relatively new, in part because the idea that cancer is survivable is too. In 1971, the year Richard Nixon declared war on cancer, there were 3 million survivors in the United States.

8 Aug 2011

FDA approves Relievant IDE for Intracept System to treat chronic low back pain

Relievant Medsystems, Inc. today announced the company has received Food and Drug Administration approval of an Investigational Device Exemption to begin their SMART pivotal trial to evaluate the safety and effectiveness of the Intracept System for treatment of chronic low back pain.

8 Aug 2011

Covalon to showcase latest line of innovative wound care and coating products at FIME Expo

Covalon Technologies Ltd., an advanced medical technologies company, today announced it is presenting its latest line of advanced wound care and medical coating products, including ColActive® Plus Ag from August 10th to 12th at FIME International Medical Expo.

8 Aug 2011

Fallout from S&P downgrade could add heightened 'super committee' focus on entitlement cuts

Speculation continues about whether the yet-to-be named panel, created by the debt deal, will be able to find the necessary budget cuts to reach the goal of $1.2 trillion in savings over the next 10 years. House Budget Committee Chairman Paul Ryan, R-Wis., is among those who have low expectations.

8 Aug 2011

Most leading health plans see enrollment gains in first quarter 2011

Most of the nation's leading health plans saw enrollment gains in the first quarter of 2011 and all saw improved profit margins both year-over-year and for the quarter, a promising start for 2011. Between December 2010 and March 2011 top plans saw an aggregate increase of more than 2.0 million members. While aggregated fully-insured business continued to experience losses, the administrative services only (ASO) segment gained over 2.2 million members during the primary 2011 open enrollment season.

8 Aug 2011

Researchers discover gene variant linked to meningiomas

The causes of brain tumours have been hard to discern in most cases. But Umeå researchers have previously identified an inherited predisposition for brain tumours, and now, in an international collaboration, they have also discovered a genetic variation that increases the risk of a certain type of brain tumour, called meningiomas.

8 Aug 2011

BioScrip second quarter revenue increases 7.1% to $441.4 million

BioScrip, Inc. today announced 2011 second quarter financial results. Second quarter revenue for the period ended June 30, 2011, was $441.4 million with a net loss of $2.3 million, or $0.04 per share, including $8.7 million in restructuring charges and a legal settlement. Excluding the after tax effect of these charges, the Company earned $0.10 per diluted share. Adjusted EBITDA for the second quarter was $18.1 million.

8 Aug 2011

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing Teva's New Drug Application (NDA) for beclomethasone dipropionate hydrofluoroalkane (BDP Nasal HFA), a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).

8 Aug 2011

Unigene second quarter revenue decreases to $2.5 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced second quarter financial results for the period ended June 30, 2011. The Company highlighted significant progress achieved in the second quarter with the continued execution of its turnaround strategy.

8 Aug 2011